These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30109140)

  • 41. Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction.
    Bidarra D; Constâncio V; Barros-Silva D; Ramalho-Carvalho J; Moreira-Barbosa C; Antunes L; Maurício J; Oliveira J; Henrique R; Jerónimo C
    Front Oncol; 2019; 9():900. PubMed ID: 31572685
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
    Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
    Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
    Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
    Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Value of serum miR-155-5p and miR-133a-3p expression for the diagnosis and prognosis evaluation of sepsis].
    Lan C; Shi X; Guo N; Pei H; Zhang H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Aug; 28(8):694-8. PubMed ID: 27434558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence.
    Sueta A; Yamamoto Y; Tomiguchi M; Takeshita T; Yamamoto-Ibusuki M; Iwase H
    Oncotarget; 2017 Sep; 8(41):69934-69944. PubMed ID: 29050253
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients.
    Ellis KL; Cameron VA; Troughton RW; Frampton CM; Ellmers LJ; Richards AM
    Eur J Heart Fail; 2013 Oct; 15(10):1138-47. PubMed ID: 23696613
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
    Yang L; Xu Q; Xie H; Gu G; Jiang J
    Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Expression and clinical significance of microRNA-21-3p and microRNA-551-5p in patients with acute pancreatitis].
    Wu K; Wang L; Fu G; Zheng Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):463-467. PubMed ID: 32527354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum miR-210-3p as a Potential Noninvasive Biomarker of Lung Adenocarcinoma: A Preliminary Study.
    Świtlik WZ; Karbownik MS; Suwalski M; Kozak J; Szemraj J
    Genet Test Mol Biomarkers; 2019 May; 23(5):353-358. PubMed ID: 30950648
    [No Abstract]   [Full Text] [Related]  

  • 51. The diagnostic values of circulating miRNAs for hypertension and bioinformatics analysis.
    Zhang X; Wang X; Wu J; Peng J; Deng X; Shen Y; Yang C; Yuan J; Zou Y
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29961674
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circulating serum miRNAs as potential biomarkers for nephroblastoma.
    Ludwig N; Nourkami-Tutdibi N; Backes C; Lenhof HP; Graf N; Keller A; Meese E
    Pediatr Blood Cancer; 2015 Aug; 62(8):1360-7. PubMed ID: 25787821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses.
    Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M
    Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of circulating microRNA signatures as potential noninvasive biomarkers for prediction and prognosis of lymph node metastasis in gastric cancer.
    Jiang X; Wang W; Yang Y; Du L; Yang X; Wang L; Zheng G; Duan W; Wang R; Zhang X; Wang L; Chen X; Wang C
    Oncotarget; 2017 Sep; 8(39):65132-65142. PubMed ID: 29029418
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating MiR-19b-3p, MiR-134-5p and MiR-186-5p are Promising Novel Biomarkers for Early Diagnosis of Acute Myocardial Infarction.
    Wang KJ; Zhao X; Liu YZ; Zeng QT; Mao XB; Li SN; Zhang M; Jiang C; Zhou Y; Qian C; Feng KG; Guan HQ; Tang TT; Cheng X; Chen ZJ
    Cell Physiol Biochem; 2016; 38(3):1015-29. PubMed ID: 26939053
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance.
    Li C; Yin Y; Liu X; Xi X; Xue W; Qu Y
    Oncotarget; 2017 Apr; 8(15):24564-24578. PubMed ID: 28445945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
    Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
    Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer.
    Wang W; Yin Y; Shan X; Zhou X; Liu P; Cao Q; Zhu D; Zhang J; Zhu W
    Am J Med Sci; 2019 Oct; 358(4):256-267. PubMed ID: 31353030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential circulating miRNA signature for early detection of NSCLC.
    Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
    Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating MicroRNAs as Novel Diagnostic Biomarkers for Very Early-onset (≤40 years) Coronary Artery Disease.
    DU Y; Yang SH; Li S; Cui CJ; Zhang Y; Zhu CG; Guo YL; Wu NQ; Gao Y; Sun J; Dong Q; Liu G; Li JJ
    Biomed Environ Sci; 2016 Aug; 29(8):545-554. PubMed ID: 27660218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.